IUCN-CEP's European Committee for National Conservation Strategies by Börlin, Max
176 Environmental Conservation
First Human Trial of Synthetic Birth-control Vaccine Begun in Australia*
Thirty women volunteered for the world's first human
trial of a synthetic birth-control vaccine, which began in
February 1986 in Adelaide, Australia—at Flinders Medical
Centre, a collaborating centre of the World Health Orga-
nization (WHO). The trial, which is part of WHO's Special
Programme of Research, Development, and Research
Training, in Human Reproduction, is scheduled to last for
nine months, and aims to determine the safety and side-
effects of the vaccine in already-sterilized women.
If this trial is successful, the vaccine will be tested on
fertile women to determine its efficacy as a birth-control
method. Also to be determined is the duration of the vac-
cine's effect, which is foreseen as likely to be between one
and two years. WHO estimates that, if all the trials proceed
satisfactorily, the vaccine could be available by the mid-
1990s.
The vaccine was developed by Ohio State University
(USA), in collaboration with other academic institutions,
the pharmaceutical industry, and WHO, over the past
* On learning of this event we asked the President of Negative
Population Growth, Inc., Donald Mann, for a comment and he
replied (in lift. 24 March 1986) that he did not feel qualified to give
an opinion on what he referred to as 'a most interesting and
promising development, indeed', but added: 'Our viewpoint is
that while improved contraceptives are essential, the heart of the
matter [lies in] motivating couples to have not more than one child
or two children at the most'—see also the Guest Comment by
Professor Gordon L. Ada on page 100 of this issue.—Ed.
decade. It has already been shown to be safe in several
animal species, and to prevent pregnancy in baboons.
'The vaccine may prove to be as important a develop-
ment in birth-control technology as the contraceptive pill',
said Mr David Griffin, a WHO official involved in the
vaccine's development. 'The vaccine offers a number of
advantages over many current methods, and this should
make it a valuable addition to the options available to the
public'. Advantages seem likely to include the simplicity of
administering it, its long-term effectiveness, and the ab-
sence of drug-related side-effects.
The vaccine is based on a hormone, human chorionic
gonadotrophin (hCG), which is produced soon after fertil-
ization and is necessary for the establishment and main-
tenance of early pregnancy. When injected, the vaccine
triggers an immune response that neutralizes the hormone,
thus interrupting the reproductive process before the fer-
tilized ovum has become implanted successfully in the
womb.
The World Health Organization chose Flinders Medical
Centre as the site of the trial because it has long been
involved in the development of the vaccine, and because it
offers the varied facilities needed for such complex
trials.
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IUCN-CEP's European Committee for National Conservation Strategies
Late in 1985, IUCN's Commission on Environmental
Planning (IUCN-CEP) decided to form a 'European Com-
mittee for National Conservation Strategies' (EC-NCS), as
a follow-up of the elaboration of the World Conservation
Strategy and as a companion, on the European scene, of the
Committee on the Ecodevelopment of Cultural Land-
scapes (CECL) which had been founded in 1971 mainly for
the Central and East European countries.
The aim of EC-NCS is to encourage, share, and discuss,
European supranational, national, and subnational, con-
servation strategies in order to learn from each other's
experience. Common interests might also lead to the pre-
paration of a European Conservation Strategy, and a
strengthening of transfrontier conservation and antipollu-
tion activities. Examples of pertinent substantive topics for
NCSs are trade and aid with the Third World, agricultural
policy, post-industrial service economy and qualitative
growth, and, of pertinent procedural topics, consensus
building tactics and strengthening of links with interna-
tional organizations.
At a meeting held in Brussels, Belgium, on 21-22 April
1986 in preparation for the Ottawa Conference on the
World Conservation Strategy, the EC-NCS realized that an
immediate step should be due involvement in the Ottawa
Conference on the World Conservation Strategy, and that
another should be to have presentations on the European
national and international conservation scenes. Later in
the year, a more direct link should be established with the
Council of Europe's 'European Campaign for the Country-
side 1987-88', and with the 'European Environment Year
1987' which has been designated by the European Econ-
omic Community and should give further impetus to
actions.
Potential members of the EC-NCS are invited by the
undersigned to participate on an ad hoc basis amongst
teams interested in and working on National and Regional
Conservation Strategies in Western European Countries.
Experts wishing to receive more information are requested
to contact the undersigned.
MAX BORLIN, Chairman of EC-NCS
Chemin des Bosquets
1297 Founex
Vaud, Switzerland.
Interuniversity Postgraduate Programme in Hydrology
First YearUnder the sponsorship of the Belgian National Commit-
tee of the International Hydrological Programme and
UNESCO, this programme, involving formal instruction
extending over one or two years, includes an orientation in
water pollution control. In addition, seminars—mainly
presented by invited guest-lecturers—provide a broad
background of both general and some specific environmen-
tal aspects.
This leads to a Diploma in Hydrology or a Certificate,
and includes:
— Prerequisites (if necessary),
— Basic courses (420 hrs) in Open-channel hydraulics,
Hydrometry, General meteorology and climatolo-
gy, Hydrometeorology, Surface-water hydrology,
https:/www.cambridge.org/core/terms. https://doi.org/10.1017/S0376892900036870
Downloaded from https:/www.cambridge.org/core. University of Basel Library, on 11 Jul 2017 at 13:49:18, subject to the Cambridge Core terms of use, available at
